Online citations, reference lists, and bibliographies.
← Back to Search

Value Of PAX8, PAX2, Napsin A, Carbonic Anhydrase IX, And Claudin-4 Immunostaining In Distinguishing Pleural Epithelioid Mesothelioma From Metastatic Renal Cell Carcinoma

N. Ordóñez
Published 2013 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Both mesotheliomas and renal cell carcinomas can present a wide variety of cytomorphologic features and histologic patterns. Because of this, renal cell carcinomas metastatic to the pleura and lung can be confused with mesotheliomas. Recently, a variety of positive carcinoma markers, including kidney-associated markers, have become available. The aim of this study is to investigate the value of some of these markers, specifically PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4, for assisting in distinguishing pleural epithelioid mesotheliomas from metastatic renal cell carcinomas. To do so, a total of 40 pleural epithelioid mesotheliomas and 55 renal cell carcinomas (33 clear cell, 10 papillary, and 12 chromophobe) were investigated. In all, 91% of the renal cell carcinomas expressed claudin-4, 89% PAX8, 60% PAX2, 71% carbonic anhydrase IX, and 29% napsin A. All of the mesotheliomas were positive for carbonic anhydrase IX and were negative for all of the other markers. On the basis of these results, it is concluded that claudin-4 and PAX8 have a higher sensitivity and specificity for assisting in discriminating between pleural epithelioid mesotheliomas and renal cell carcinomas when compared with all of the other positive carcinoma markers that are, at present, recommended to be included in the immunohistochemical panels used in this differential diagnosis. Even though PAX2 and napsin A are highly specific, because of their low sensitivity, they have only a limited value. Carbonic anhydrase IX is not useful.
This paper references
10.1046/j.1365-2559.2000.00770.x
HBME‐1, MOC‐31, WT1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma
Oates (2000)
10.1097/00000478-200105000-00007
Calretinin and Other Mesothelioma Markers in Synovial Sarcoma: Analysis of Antigenic Similarities and Differences With Malignant Mesothelioma
M. Miettinen (2001)
10.1097/PAP.0b013e318253465d
Value of PAX 8 Immunostaining in Tumor Diagnosis: A Review and Update
N. Ordóñez (2012)
10.1053/HUPA.2001.22753
Pax-2 expression in adult renal tumors.
L. Daniel (2001)
10.1016/S0046-8177(03)00177-1
Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas.
H. Frierson (2003)
10.1097/00005392-199805000-00146
Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney.
S. Liao (1997)
10.1210/EN.2006-1054
Congenital hypothyroid female pax8-deficient mice are infertile despite thyroid hormone replacement therapy.
J. Mittag (2007)
10.1016/j.ejca.2010.07.020
Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment.
J. Tostain (2010)
10.1097/00000478-199712000-00002
The value of antibodies 44-3A6, SM3, HBME-1, and thrombomodulin in differentiating epithelial pleural mesothelioma from lung adenocarcinoma: a comparative study with other commonly used antibodies.
N. Ordóñez (1997)
10.1097/00000478-199609000-00001
Calretinin: a novel immunocytochemical marker for mesothelioma.
C. Doglioni (1996)
10.1097/00000478-200308000-00001
The Immunohistochemical Diagnosis of Mesothelioma: A Comparative Study of Epithelioid Mesothelioma and Lung Adenocarcinoma
N. Ordóñez (2003)
10.1097/PAS.0b013e3181da7687
PAX8 Reliably Distinguishes Ovarian Serous Tumors From Malignant Mesothelioma
Anna R. Laury (2010)
10.1097/PAI.0b013e318205b059
Combination of Napsin A and TTF-1 Immunohistochemistry Helps in Differentiating Primary Lung Adenocarcinoma From Metastatic Carcinoma in the Lung
J. Ye (2011)
The utility of PAX-2 and renal cell carcinoma marker Modern Pathology
SG Sharma (2013)
10.5858/arpa.2012-0214-OA
Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.
A. Husain (2013)
10.1136/jcp.50.10.859
HBME-1 and antithrombomodulin in the differential diagnosis of malignant mesothelioma of pleura.
A. Kennedy (1997)
10.1097/PAI.0b013e3182025f66
Expression of PAX8 in Normal and Neoplastic Tissues: A Comprehensive Immunohistochemical Study
D. Tacha (2011)
10.1038/modpathol.2012.200
Value of PAX8, PAX2, claudin-4, and h-caldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomas
N. Ordóñez (2013)
Compar - ison of putative renal cell carcinoma ( RCC ) immunohistochemical ( IHC ) markers in primary adrenal cortical lesions ( ACL ) and metastatic RCC : a tissue microarray study of 246 cases
JK McKenney (2009)
Pax-2 controls multiple steps of urogenital development.
M. Torres (1995)
10.1016/0046-8177(90)90036-5
Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: a histochemical, ultrastructural, and immunohistologic study of 103 cases.
M. Wick (1990)
10.1097/PAS.0b013e3181570343
Carbonic Anhydrase IX Expression in Clear Cell Renal Cell Carcinoma: An Immunohistochemical Study Comparing 2 Antibodies
H. Al-Ahmadie (2008)
10.1002/IJC.2910610503
International renal‐cell cancer study. IV. Occupation
J. S. Mandel (1995)
10.1200/JCO.2007.12.1087
Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma.
B. Leibovich (2007)
10.1097/PAI.0b013e3181d712ef
PAX-2 Expression in Non-neoplastic, Primary Neoplastic, and Metastatic Neoplastic Tissue: A Comprehensive Immunohistochemical Study
Q. J. Zhai (2010)
10.1016/j.humpath.2012.05.014
Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update.
N. Ordóñez (2013)
10.1097/01.pas.0000163362.78475.63
Distribution of Cytokeratins and Vimentin in Adult Renal Neoplasms and Normal Renal Tissue: Potential Utility of a Cytokeratin Antibody Panel in the Differential Diagnosis of Renal Tumors
B. Skinnider (2005)
10.1136/jcp.2005.028589
Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura
Y. Soini (2006)
10.1097/00004347-200104000-00007
The Value of Immunocytochemistry in Distinguishing Between Clear Cell Carcinoma of the Kidney and Ovary
L. Nolan (2001)
10.1038/modpathol.3800236
CD10 is expressed in a subset of chromophobe renal cell carcinomas
G. Martignoni (2004)
10.1038/modpathol.3880386
Parvalbumin Is Constantly Expressed in Chromophobe Renal Carcinoma
G. Martignoni (2001)
10.1016/0007-0971(76)90039-5
Distant visceral metastases in pleural mesothelioma.
G. H. Roberts (1976)
10.1097/00000478-200112000-00003
Diagnosing Primary and Metastatic Renal Cell Carcinoma: The Use of the Monoclonal Antibody `Renal Cell Carcinoma Marker'
D. K. McGregor (2001)
10.1038/modpathol.3800827
Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Müllerian system origin?
G. Tong (2007)
10.1053/HUPA.2001.24329
Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
C. Comin (2001)
10.1016/J.HUMPATH.2003.11.013
The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: a comparative study.
N. Ordóñez (2004)
10.1097/00129039-200306000-00003
Renal Cell Carcinoma Antigen Is Expressed by Yolk Sac Tumors and Yolk Sac Elements of Embryonal Carcinomas
M. Yan (2003)
10.1016/S0002-9440(10)62528-X
cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma.
S. Y. Xiao (2001)
10.1111/j.1365-2559.1995.tb01527.x
A comparative immunohistochemical study of malignant mesothelioma and renal cell carcinoma: the diagnostic utility of Leu‐M1, Ber EP4, Tamm‐Horsfall protein and thrombomodulin
R. Attanoos (1995)
10.1016/0046-8177(93)90080-Z
Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma.
R. Brown (1993)
10.1097/00000478-200004000-00016
Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma.
N. Ordóñez (2000)
10.1097/00000478-200311000-00003
Application of Mesothelin Immunostaining in Tumor Diagnosis
N. Ordóñez (2003)
10.1146/ANNUREV.BI.64.070195.002111
Human carbonic anhydrases and carbonic anhydrase deficiencies.
W. Sly (1995)
10.1016/J.HUMPATH.2005.02.014
Mesothelioma with clear cell features: an ultrastructural and immunohistochemical study of 20 cases.
N. Ordóñez (2005)
10.1679/AOHC.65.359
Immunohistochemical localization of napsin and its potential role in protein catabolism in renal proximal tubules.
K. Mori (2002)
10.1309/9KWEA4W9Y94D1AEE
Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma.
L. Memeo (2007)
10.1002/DC.20747
Utility of WT‐1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions
Robert T. Pu (2008)
10.1111/j.1365-2559.2011.03753.x
Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C‐kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics
Jason C. Carvalho (2011)
10.1046/j.1365-2559.2002.14044.x
Foamy cell mesothelioma
A. Cavazza (2002)
10.1016/S0002-9440(10)64038-2
Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer.
S. Ivanov (2001)
10.1016/S0169-5002(03)00194-6
Usefulness of TA02 (napsin A) to distinguish primary lung adenocarcinoma from metastatic lung adenocarcinoma.
T. Hirano (2003)
10.1097/PAS.0b013e3182064d11
PAX2(−)/PAX8(−)/Inhibin A(+) Immunoprofile in Hemangioblastoma: A Helpful Combination in the Differential Diagnosis With Metastatic Clear Cell Renal CellCarcinoma to the Central Nervous System
E. Carney (2011)
10.1097/00000478-200110000-00010
Metanephric Adenoma, Nephrogenic Rests, and Wilms' Tumor: A Histologic and Immunophenotypic Comparison
T. Muir (2001)
10.1097/00000478-199712000-00003
The immunohistochemical diagnostic panel for epithelial mesothelioma: a reevaluation after heat-induced epitope retrieval.
J. R. Riera (1997)
10.1038/modpathol.2011.3
PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study
A. Ozcan (2011)
10.1038/283583A0
A monoclonal antibody to human acute lymphoblastic leukaemia antigen
J. Ritz (1980)
10.1038/modpathol.2009.88
Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study
G. Tong (2009)
10.1053/S0046-8177(03)00339-3
Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissue samples.
A. Lugli (2003)
10.1002/dc.20839
Comparison of PAX‐2, RCC antigen, and antiphosphorylated H2AX antibody (γ‐H2AX) in diagnosing metastatic renal cell carcinoma by fine‐needle aspiration
Matthew J. Wasco (2008)
10.1097/PAP.0b013e31823e472e
Napsin A expression in lung and kidney neoplasia: a review and update.
N. Ordóñez (2012)
10.1111/j.1440-1843.2005.00652.x
Metastatic renal cell carcinoma presenting as multiple pleural tumours
H. Ohnishi (2005)
10.1043/1543-2165(2007)131[1290:IAOCRC]2.0.CO;2
Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis.
L. Liu (2007)
10.1097/01.MP.0000056981.16578.C3
Value of Mesothelin Immunostaining in the Diagnosis of Mesothelioma
N. Ordóñez (2003)
10.1097/PAI.0b013e3181ddf7b9
Distinguishing Clear Cell Renal Cell Carcinoma, Retroperitoneal Paraganglioma, and Adrenal Cortical Lesions on Limited Biopsy Material: Utility of Immunohistochemical Markers
James Lapinski (2010)
10.1111/j.1365-2559.2008.03003.x
Renal cell carcinoma marker reliably discriminates central nervous system haemangioblastoma from brain metastases of renal cell carcinoma
B. Ingold (2008)
10.1111/j.1365-2559.2005.02279.x
The use of the monoclonal antibody mesothelin in the diagnosis of malignant mesothelioma in pleural biopsies
M. Galloway (2006)
10.1097/01.pai.0000146525.72531.19
Differential Immunoprofiles of Hepatocellular Carcinoma, Renal Cell Carcinoma, and Adrenocortical Carcinoma: A Systemic Immunohistochemical Survey Using Tissue Array Technique
Chin-Chen Pan (2005)
10.1111/j.1365-2559.2005.02127.x
Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours
Y. Soini (2005)
10.1038/modpathol.3800259
Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma
Albert Y Chu (2005)
10.1097/00022744-200212000-00008
Immunohistochemical Profile of Common Epithelial Neoplasms Arising in the Kidney
M. Kim (2002)
10.1097/00000478-199810000-00006
Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma.
N. Ordóñez (1998)
10.1007/s00428-007-0448-x
Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions
F. Facchetti (2007)
10.1097/PAS.0b013e3182152629
Immunohistochemical Distinction of Primary Adrenal Cortical Lesions From Metastatic Clear Cell Renal Cell Carcinoma: A Study of 248 Cases
A. Sangoi (2011)
10.1097/01.pas.0000180443.94645.50
Immunohistochemical Analysis of Mucinous Tubular and Spindle Cell Carcinoma and Papillary Renal Cell Carcinoma of the Kidney: Significant Immunophenotypic Overlap Warrants Diagnostic Caution
G. Paner (2006)
10.1097/00000478-198904000-00003
The Immunohistochemical Diagnosis of Mesothelioma: Differentiation of Mesothelioma and Lung Adenocarcinoma
N. Ordóñez (1989)
10.1016/j.humpath.2009.05.006
Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis.
A. Osunkoya (2009)
10.1097/00000478-200302000-00002
Expression of Calretinin, Thrombomodulin, Keratin 5, and Mesothelin in Lung Carcinomas of Different Types: An Immunohistochemical Analysis of 596 Tumors in Comparison With Epithelioid Mesotheliomas of the Pleura
M. Miettinen (2003)
10.1387/IJDB.10535325
Pax2 in development and renal disease.
G. Dressler (1999)
10.1111/j.1600-0560.2010.01564.x
PAX8 discriminates ovarian metastases from adnexal tumors and other cutaneous metastases
M. Fujiwara (2010)
10.1111/j.1365-2559.2004.01962.x
The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases
C. Pan (2004)
International renal-cell cancer
JS Mandel (1995)
10.1038/modpathol.3800544
The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study
N. Ordóñez (2006)
10.1097/PAS.0b013e318176dba7
The Utility of PAX-2 in Distinguishing Metastatic Clear Cell Renal Cell Carcinoma From its Morphologic Mimics: An Immunohistochemical Study With Comparison to Renal Cell Carcinoma Marker
N. Gokden (2008)
Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma.
N. Ordóñez (1998)
10.1097/00000478-200101000-00004
Immunohistochemical Panels For Differentiating Epithelial Malignant Mesothelioma From Lung Adenocarcinoma: A Study With Logistic Regression Analysis
R. Carella (2001)
10.1097/PAI.0b013e3181dd35d2
Clear Cell Meningioma: A Clinicopathologic Study of 18 Tumors and Examination of the Use of CD10, CA9, and RCC Antibodies to Distinguish Between Clear Cell Meningioma and Metastatic Clear Cell Renal Cell Carcinoma
R. Prayson (2010)
10.1038/modpathol.3800320
Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study
P. Mazal (2005)
10.1523/JNEUROSCI.14-03-01395.1994
Roles of Pax-genes in developing and adult brain as suggested by expression patterns
A. Stoykova (1994)
10.1080/003655999750016186
Metastatic renal cell carcinoma mimicking pleural mesothelioma.
T. Azuma (1999)
Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma.
C. L. Collins (1992)
10.1097/PAS.0b013e3181e8ce5b
Xp11 Translocation Renal Cell Carcinoma (RCC): Extended Immunohistochemical Profile Emphasizing Novel RCC Markers
P. Argani (2010)
10.1097/PAS.0b013e318181b828
Diagnostic Implications of Transcription Factor Pax 2 Protein and Transmembrane Enzyme Complex Carbonic Anhydrase IX Immunoreactivity in Adult Renal Epithelial Neoplasms
R. Gupta (2009)
10.1002/DC.20667
Napsin A (TA02) is a useful alternative to thyroid transcription factor‐1 (TTF‐1) for the identification of pulmonary adenocarcinoma cells in pleural effusions
A. Dejmek (2007)
10.1111/j.1440-1789.2010.01109.x
Useful immunohistochemical markers in differentiating hemangioblastoma versus metastatic renal cell carcinoma
A. Rivera (2010)
10.1002/cncy.20108
The utility of napsin‐A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas
L. Stoll (2010)
10.1002/dc.21375
Immunohistochemistry for the detection of renal cell carcinoma in effusion cytology
D. Chute (2011)
10.1111/j.1464-410X.2005.05615.x
Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma
J. Leppert (2005)
10.1136/thx.42.11.901
Metastatic renal cell carcinoma mimicking pleural mesothelioma.
D. R. Taylor (1987)
10.1097/00000478-200002000-00006
Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms.
A. Avery (2000)
10.1016/J.HUMPATH.2005.08.008
Value of estrogen and progesterone receptor immunostaining in distinguishing between peritoneal mesotheliomas and serous carcinomas.
N. Ordóñez (2005)
10.1111/j.1365-2559.2007.02900.x
Profiling and classification tree applied to renal epithelial tumours
Y. Allory (2008)
10.1097/PAP.0b013e318271a382
Value of PAX2 Immunostaining in Tumor Diagnosis: A Review and Update
N. Ordóñez (2012)
10.1111/j.1365-2559.2004.01982.x
CD10 is a diagnostic and prognostic marker in renal malignancies
C. Langner (2004)
10.1046/j.1365-2559.2003.01674.x
‘Pseudomesotheliomatous’ carcinomas of the pleura: a 10‐year analysis of cases from the Environmental Lung Disease Research Group, Cardiff
R. Attanoos (2003)
10.1158/0008-5472.CAN-03-2224
Role of Carbonic Anhydrase IX in Human Tumor Cell Growth, Survival, and Invasion
N. Robertson (2004)
10.1046/J.1365-2559.2002.01527.X
The value of 'mesothelium-associated' antibodies in distinguishing between metastatic renal cell carcinomas and mesotheliomas.
M. Osborn (2002)
10.1043/1543-2165(2006)130[823:EORCCM]2.0.CO;2
Expression of renal cell carcinoma-associated markers erythropoietin, CD10, and renal cell carcinoma marker in diffuse malignant mesothelioma and metastatic renal cell carcinoma.
K. Butnor (2006)
10.1309/AJCPM7DW0XFHDHNY
PAX-2 in the diagnosis of primary renal tumors: immunohistochemical comparison with renal cell carcinoma marker antigen and kidney-specific cadherin.
A. Ozcan (2009)
10.1097/00004347-200104000-00007
The Value of Immunocytochemistry in Distinguishing Between Clear Cell Carcinoma of the Kidney and Ovary
Nolan Lp (2001)
10.1097/01.pai.0000213144.70148.8e
Expression of Renal Cell Carcinoma Antigen (RCC) in Renal Epithelial and Nonrenal Tumors: Diagnostic Implications
N. Bakshi (2007)
10.1043/2010-0478-RAR.1
Immunohistochemical diagnosis of renal neoplasms.
L. Truong (2011)
10.1016/j.humpath.2009.06.014
Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
J. Bishop (2010)
10.1023/A:1008905302597
Kidney cancer and occupational exposure to asbestos: a meta-analysis of occupational cohort studies
D. Sali (2004)
Metanephric adenoma, nephrogenic rests, and Wilms’ tumor: a histologic Modern Pathology
TE Muir (2013)
10.1097/PAI.0b013e3181e78ff8
The Utility of Pax-2 and Renal Cell Carcinoma Marker Immunohistochemistry in Distinguishing Papillary Renal Cell Carcinoma From Nonrenal Cell Neoplasms With Papillary Features
S. Sharma (2010)
10.1309/AJCPPPR57HNJMSLZ
Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade.
E. Genega (2010)
Monoclonal antibody to a proximal nephrogenic renal antigen: immunohistochemical analysis of formalin-fixed, paraffin-embedded human renal cell carcinomas.
S. Yoshida (1989)
10.1148/121.1.43
Thoracic manifestations of renal cell carcinoma.
A. Latour (1976)
10.1038/sj.bjc.6600936
Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer
C. Potter (2003)
10.1007/s00428-011-1178-7
Carbonic anhydrase IX is expressed in mesothelioma and metastatic clear cell renal cell carcinoma of the lung
Mitchell L. Ramsey (2011)
10.1111/j.1365-2559.2009.03322.x
Caveolin‐1 is a novel immunohistochemical marker to differentiate epithelioid mesothelioma from lung adenocarcinoma
V. Amatya (2009)
10.1046/j.1365-2559.2001.01215.x
CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms
W. G. McCluggage (2001)



This paper is referenced by
10.1016/j.humpath.2020.05.007
Napsin A is a highly sensitive marker for nephrogenic adenoma: an immunohistochemical study with specificity test in genitourinary tumors.
N. Sharifai (2020)
10.1016/j.humpath.2020.04.005
Claudin-4 Shows Superior Specificity for Mesothelioma vs Non-Small Cell Lung Carcinoma Compared to MOC-31 and Ber-EP4.
Julia R Naso (2020)
10.1007/978-3-030-16884-1_7
Pathological Diagnosis of Mesothelioma
G. Fontanini (2019)
10.1007/s12105-018-0973-8
CAIX and pax-8 Commonly Immunoreactive in Endolymphatic Sac Tumors: A Clinicopathologic Study of 26 Cases with Differential Considerations for Metastatic Renal Cell Carcinoma in von Hippel-Lindau Patients
L. Thompson (2018)
10.1007/978-3-319-57386-1
Handbook of Practical Fine Needle Aspiration and Small Tissue Biopsies
Ph.D. Fan Lin (2018)
10.1097/PAP.0000000000000069
Metastatic Carcinoma of Unknown Primary: Diagnostic Approach Using Immunohistochemistry
J. Conner (2015)
10.1007/978-3-319-57386-1_1
Introduction and Application of Fine Needle Aspiration Biopsy
F. Lin (2018)
10.1016/j.humpath.2016.08.005
CD24 is highly useful in differentiating high-grade serous carcinoma from benign and malignant mesothelial cells.
B. Davidson (2016)
10.1007/978-1-4939-1578-1_11
Unknown Primary/Undifferentiated Neoplasm
F. Lin (2015)
10.1016/j.humpath.2012.11.016
Broad-spectrum immunohistochemical epithelial markers: a review.
N. Ordóñez (2013)
10.1002/cncy.21392
Claudin‐4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology
V. Jo (2014)
10.1016/J.JASC.2013.11.005
Napsin A expression in small cell carcinoma of the lung: a cytologic study with review of differentials.
K. Hookim (2014)
10.1097/PAI.0b013e31829b6fbd
Value of Calretinin Immunostaining in Diagnostic Pathology: A Review and Update
N. Ordóñez (2014)
10.1007/978-1-4939-1607-8_9
Evaluation of Small Biopsy Material in Patients with Multiple and Secondary Tumors
S. Monaco (2015)
10.1007/978-1-4939-1578-1_12
Exfoliative Cytology and Effusions
S. Meschter (2015)
10.1177/0300985817698211
Pax8, Napsin A, and CD10 as Immunohistochemical Markers of Canine Renal Cell Carcinoma
Tyler J. Peat (2017)
10.1007/s00428-017-2273-1
The diagnostic role of PTEN and ARID1A in serous effusions
B. Davidson (2017)
10.1016/j.humpath.2014.03.006
Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study.
N. Ordóñez (2014)
10.5858/arpa.2017-0092-OA
Immunohistochemistry in Peritoneal Mesothelioma: A Single-Center Experience of 244 Cases.
R. Tandon (2018)
10.21037/jtd.2017.10.125
The pathological and molecular diagnosis of malignant pleural mesothelioma: a literature review.
G. Alí (2018)
10.1016/j.humpath.2018.05.012
The diagnostic role of BAP1 in serous effusions.
B. Davidson (2018)
10.5858/arpa.2017-0537-RA
The Diagnosis of Pleural Tumors Other Than Mesothelioma.
R. Attanoos (2018)
10.5858/arpa.2014-0061-RA
Immunohistochemistry in undifferentiated neoplasm/tumor of uncertain origin.
Fan Li-n (2014)
10.1016/j.jcpa.2016.07.009
Immunohistochemical Detection of Pax8 and Napsin A in Canine Thyroid Tumours: Comparison with Thyroglobulin, Calcitonin and Thyroid Transcription Factor 1.
J. Ramos-Vara (2016)
Semantic Scholar Logo Some data provided by SemanticScholar